Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Amneal: Q1 Earnings Snapshot AP - Fri May 3, 5:07AM CDT

Amneal: Q1 Earnings Snapshot

AMRX : 6.76 (+0.45%)
Amneal: Q4 Earnings Snapshot AP - Fri Mar 1, 5:23AM CST

Amneal: Q4 Earnings Snapshot

AMRX : 6.76 (+0.45%)
Amneal: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Amneal: Q3 Earnings Snapshot

AMRX : 6.76 (+0.45%)
Amneal: Q2 Earnings Snapshot AP - Fri Aug 4, 2023

Amneal: Q2 Earnings Snapshot

AMRX : 6.76 (+0.45%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amneal Pharmaceuticals, Inc. - AMRX PR Newswire - Mon Jul 17, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NYSE: AMRX). Such...

AMRX : 6.76 (+0.45%)
MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall, Wednesday, 7/5/2023 Associated Press - Wed Jul 5, 2023

Stocks that traded heavily or had substantial price changes on Wednesday: MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall

BRGYY : 15.2200 (unch)
AMRX : 6.76 (+0.45%)
INCY : 57.24 (+0.09%)
BG : 103.01 (+0.71%)
VRTX : 438.44 (-1.67%)
CVX : 160.09 (-0.65%)
UPS : 145.53 (-1.40%)
Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday Motley Fool - Wed Jul 5, 2023

The company received a complete response letter from the FDA regarding a Parkinson's disease generic therapy.

AMRX : 6.76 (+0.45%)
Amneal: Q1 Earnings Snapshot AP - Fri May 5, 2023

Amneal: Q1 Earnings Snapshot

AMRX : 6.76 (+0.45%)
Amneal Reports First Quarter 2023 Financial Results Business Wire - Fri May 5, 2023

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced its actual results today for the first quarter ended March 31, 2023.

AMRX : 6.76 (+0.45%)
Earnings Preview: Theravance Biopharma (TBPH) Q1 Earnings Expected to Decline Zacks - Mon May 1, 2023

Theravance Bio (TBPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TBPH : 8.91 (-2.09%)
AMRX : 6.76 (+0.45%)

Barchart Exclusives

Investing in Gold? Forget GLD, Buy PHYS Instead Barchart - 3 minutes ago
Many groups are piling into gold, including central banks and sovereign governments. Gold has also become very popular among individual Chinese investors and family offices that cater to the global rich. Most of these investors choose physical gold. That's what famed investor Michael Burry did. But instead of the GLD ETF, he opted for another physical gold ETF - PHYS. Find out why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot